Citius Pharmaceuticals
CTXR
CTXR
76 hedge funds and large institutions have $43.2M invested in Citius Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.01% less ownership
Funds ownership: 0.67% → 0.66% (-0.01%)
27% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 26
Holders
76
Holding in Top 10
–
Calls
$1.05M
Puts
$135K
Top Buyers
| 1 | +$399K | |
| 2 | +$162K | |
| 3 | +$124K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$114K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$84K |
Top Sellers
| 1 | -$249K | |
| 2 | -$211K | |
| 3 | -$156K | |
| 4 |
HF
HRT Financial
New York
|
-$139K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$130K |